争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2024
FDA对雅培HeartMate心脏泵发布一级召回
宣布召回
FDA对雅培子公司Thoratec生产的HeartMate II和HeartMate 3心脏泵发布了最严重级别的召回,涉及近14,000台设备。设备可能出现生物材料积聚,降低血液流动能力;报道指出,FDA将该召回与数百起伤害和至少14起死亡联系起来。
品牌回应
持续披露 — Abbott
In a written response, Abbott said it had communicated the risk to customers this year.
来源摘录
A pair of heart devices manufactured by a subsidiary of North Chicago-based Abbott Laboratories has received the FDA’s most serious recall after being linked to hundreds of injuries and at least 14 deaths, the agency has announced.
According to the FDA’s recall notice, the devices can cause buildup of “biological material” that reduces their ability to help the heart circulate blood and keep patients alive.
The recall affects nearly 14,000 devices.